Cargando…
Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis
BACKGROUND: Anti-citrullinated protein antibodies (ACPAs) are highly specific for rheumatoid arthritis (RA). In vivo, ACPAs target peptidyl-citrulline epitopes (cit-) in a variety of proteins (cit-prot-ACPAs) and derived peptides (cit-pept-ACPAs) generated via the peptidylarginine deiminase (PAD) is...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756661/ https://www.ncbi.nlm.nih.gov/pubmed/35027076 http://dx.doi.org/10.1186/s13075-021-02698-2 |
_version_ | 1784632606635065344 |
---|---|
author | de França, Natalia Regine Ménard, Henri André Lora, Maximilien Zhou, Zhijie Rauch, Joyce Hitchon, Carol Andrade, Luís Eduardo Coelho Colmegna, Inés |
author_facet | de França, Natalia Regine Ménard, Henri André Lora, Maximilien Zhou, Zhijie Rauch, Joyce Hitchon, Carol Andrade, Luís Eduardo Coelho Colmegna, Inés |
author_sort | de França, Natalia Regine |
collection | PubMed |
description | BACKGROUND: Anti-citrullinated protein antibodies (ACPAs) are highly specific for rheumatoid arthritis (RA). In vivo, ACPAs target peptidyl-citrulline epitopes (cit-) in a variety of proteins (cit-prot-ACPAs) and derived peptides (cit-pept-ACPAs) generated via the peptidylarginine deiminase (PAD) isoenzymes. We aimed to identify a cell line with self-citrullination capacity, to describe its autoantigenic citrullinome, and to test it as a source of autocitrullinated proteins and peptides. METHODS: Human cell lines were screened for cit-proteins by Western blot. PAD isoenzymes were identified by RT-PCR. Autocitrullination of ECV304 was optimized, and the ECV304 autocitrullinomes immunoprecipitated by sera from three RA patients were characterized by mass spectrometry. Cit-pept-ACPAs were detected using anti-CCP2 ELISA and cit-prot-ACPAs, by an auto-cit-prot-ECV304 ELISA. Sera from 177 RA patients, 59 non-RA rheumatic disease patients and 25 non-disease controls were tested. RESULTS: Of the seven cell lines studied, only ECV304 simultaneously overexpressed PAD2 and PAD3 and its extracts reproducibly autocitrullinated self and non-self-proteins. Proteomic analysis of the cit-ECV304 products immunoprecipitated by RA sera, identified novel cit-targets: calreticulin, profilin 1, vinculin, new 14–3-3 protein family members, chaperones, and mitochondrial enzymes. The auto-cit-prot-ECV304 ELISA had a sensitivity of 50% and a specificity of 95% for RA diagnosis. CONCLUSIONS: ECV304 cells overexpress two of the PAD isoenzymes capable of citrullinating self-proteins. These autocitrullinated cells constitute a basic and clinical research tool that enable the detection of cit-prot-ACPAs with high diagnostic specificity and allow the identification of the specific cit-proteins targeted by individual RA sera. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02698-2. |
format | Online Article Text |
id | pubmed-8756661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87566612022-01-18 Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis de França, Natalia Regine Ménard, Henri André Lora, Maximilien Zhou, Zhijie Rauch, Joyce Hitchon, Carol Andrade, Luís Eduardo Coelho Colmegna, Inés Arthritis Res Ther Research Article BACKGROUND: Anti-citrullinated protein antibodies (ACPAs) are highly specific for rheumatoid arthritis (RA). In vivo, ACPAs target peptidyl-citrulline epitopes (cit-) in a variety of proteins (cit-prot-ACPAs) and derived peptides (cit-pept-ACPAs) generated via the peptidylarginine deiminase (PAD) isoenzymes. We aimed to identify a cell line with self-citrullination capacity, to describe its autoantigenic citrullinome, and to test it as a source of autocitrullinated proteins and peptides. METHODS: Human cell lines were screened for cit-proteins by Western blot. PAD isoenzymes were identified by RT-PCR. Autocitrullination of ECV304 was optimized, and the ECV304 autocitrullinomes immunoprecipitated by sera from three RA patients were characterized by mass spectrometry. Cit-pept-ACPAs were detected using anti-CCP2 ELISA and cit-prot-ACPAs, by an auto-cit-prot-ECV304 ELISA. Sera from 177 RA patients, 59 non-RA rheumatic disease patients and 25 non-disease controls were tested. RESULTS: Of the seven cell lines studied, only ECV304 simultaneously overexpressed PAD2 and PAD3 and its extracts reproducibly autocitrullinated self and non-self-proteins. Proteomic analysis of the cit-ECV304 products immunoprecipitated by RA sera, identified novel cit-targets: calreticulin, profilin 1, vinculin, new 14–3-3 protein family members, chaperones, and mitochondrial enzymes. The auto-cit-prot-ECV304 ELISA had a sensitivity of 50% and a specificity of 95% for RA diagnosis. CONCLUSIONS: ECV304 cells overexpress two of the PAD isoenzymes capable of citrullinating self-proteins. These autocitrullinated cells constitute a basic and clinical research tool that enable the detection of cit-prot-ACPAs with high diagnostic specificity and allow the identification of the specific cit-proteins targeted by individual RA sera. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13075-021-02698-2. BioMed Central 2022-01-13 2022 /pmc/articles/PMC8756661/ /pubmed/35027076 http://dx.doi.org/10.1186/s13075-021-02698-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article de França, Natalia Regine Ménard, Henri André Lora, Maximilien Zhou, Zhijie Rauch, Joyce Hitchon, Carol Andrade, Luís Eduardo Coelho Colmegna, Inés Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
title | Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
title_full | Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
title_fullStr | Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
title_full_unstemmed | Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
title_short | Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
title_sort | characterization and use of the ecv304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756661/ https://www.ncbi.nlm.nih.gov/pubmed/35027076 http://dx.doi.org/10.1186/s13075-021-02698-2 |
work_keys_str_mv | AT defrancanataliaregine characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT menardhenriandre characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT loramaximilien characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT zhouzhijie characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT rauchjoyce characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT hitchoncarol characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT andradeluiseduardocoelho characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis AT colmegnaines characterizationanduseoftheecv304autoantigeniccitrullinometounderstandanticitrullinatedproteinpeptideautoantibodiesinrheumatoidarthritis |